These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 38419696)

  • 1. Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway.
    Bhidayasiri R; Phokaewvarangkul O; Shang HF; Lim TT; Cho JW; Pal PK; Watanabe H
    Front Neurol; 2024; 15():1356761. PubMed ID: 38419696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive Dyskinesia.
    Tarsy D
    Curr Treat Options Neurol; 2000 May; 2(3):205-214. PubMed ID: 11096748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs.
    Tarsy D; Lungu C; Baldessarini RJ
    Handb Clin Neurol; 2011; 100():601-16. PubMed ID: 21496610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.
    El-Sayeh HG; Rathbone J; Soares-Weiser K; Bergman H
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD000458. PubMed ID: 29342497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
    Carbon M; Hsieh CH; Kane JM; Correll CU
    J Clin Psychiatry; 2017 Mar; 78(3):e264-e278. PubMed ID: 28146614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis.
    Barer Y; Ribalov R; Yaari A; Maor R; Arow Q; Logan J; Chodick G; Arkadir D; Eitan R
    J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):454-460. PubMed ID: 36018237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Strategies for Tardive Dyskinesia.
    Kremens DE
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31880872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tardive dyskinesia: Who gets it and why.
    Frei K
    Parkinsonism Relat Disord; 2019 Feb; 59():151-154. PubMed ID: 30522959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Tardive Dyskinesia.
    Bashir HH; Jankovic J
    Neurol Clin; 2020 May; 38(2):379-396. PubMed ID: 32279716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Historical comments on tardive dyskinesia: a neurologist's perspective.
    Paulson GW
    J Clin Psychiatry; 2005 Feb; 66(2):260-4. PubMed ID: 15705014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.
    Ward KM; Citrome L
    Neurol Ther; 2018 Dec; 7(2):233-248. PubMed ID: 30027457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia in a South Asian population with first episode psychosis treated with antipsychotics.
    Adam UU; Husain N; Haddad PM; Munshi T; Tariq F; Naeem F; Chaudhry IB
    Neuropsychiatr Dis Treat; 2014; 10():1953-9. PubMed ID: 25342903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia.
    Bergman H; Walker DM; Nikolakopoulou A; Soares-Weiser K; Adams CE
    Health Technol Assess; 2017 Aug; 21(43):1-218. PubMed ID: 28812541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V.
    van Harten PN; Hoek HW; Matroos GE; van Os J
    J Clin Psychiatry; 2006 Dec; 67(12):1920-7. PubMed ID: 17194270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive Dyskinesia in Older Persons Taking Antipsychotics.
    Citrome L; Isaacson SH; Larson D; Kremens D
    Neuropsychiatr Dis Treat; 2021; 17():3127-3134. PubMed ID: 34703232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telehealth for Assessing and Managing Tardive Dyskinesia: Expert Insights from a Cross-Disciplinary Virtual Treatment Panel.
    El-Mallakh RS; Belnap A; Iyer S; Schreiber J; Matthews D; Lefler L; Dees D; Bott A; Vanegas-Arroyave N; Wolff A; Pesce U; Farahmand K; Shah C; Lundt L
    Telemed J E Health; 2023 Jul; 29(7):1096-1104. PubMed ID: 36520584
    [No Abstract]   [Full Text] [Related]  

  • 19. The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation.
    Farber RH; Stull DE; Witherspoon B; Evans CJ; Yonan C; Bron M; Dhanda R; Jen E; Brien CO'
    J Patient Rep Outcomes; 2024 Jan; 8(1):2. PubMed ID: 38175450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk factors for the development of tardive dyskinesia.
    Solmi M; Pigato G; Kane JM; Correll CU
    J Neurol Sci; 2018 Jun; 389():21-27. PubMed ID: 29439776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.